On Friday, Baker Hughes got an upgrade for its IBD SmartSelect Composite Rating from 91 to 99.
The revised score means the stock currently tops 99% of all other stocks in terms of key performance metrics and technical strength.
Baker Hughes is now out of buy range after clearing the 27.66 entry in a consolidation.
See How IBD Helps You Make More Money In Stocks
The stock has a 91 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 91% of all stocks.
Its Accumulation/Distribution Rating of A- shows heavy buying by institutional investors over the last 13 weeks.
The company posted a 255% earnings-per-share gain for Q2. It has now posted accelerating EPS gains for two consecutive quarters. Sales growth climbed 25%, up from 18% in the prior report. That marks four consecutive reports with rising growth.
Baker Hughes earns the No. 1 rank among its peers in the Oil & Gas-Machinery/Equipment industry group. Weatherford Intl and Archrock are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
